Yingli Pharma Announces Successful End-of-Phase 2 Meeting with FDA and Clearance of Global Multi-center Phase 3 Registration Study Design of Linperlisib for the Treatment of Relapsed and/or Refractory Peripheral T-cell Lymphoma
SAN FRANCISCO, April 1, 2025 /PRNewswire/ -- Shanghai Yingli Pharmaceutical Co., Ltd. (Yingli Pharma), a clinical stage biotechnology company developing oral small molecule drugs for cancer, metabolic, and immune diseases, announced today that it...
Mega Matrix Inc. Filed 2024 Annual Report on Form 20-F
SINGAPORE, April 1, 2025 /PRNewswire/ -- Mega Matrix Inc. ("MPU" or the "Company") (NYSE American: MPU), a short-video streaming platform and producer of short dramas, announces that it has filed its annual report on Form 20-F for the fiscal year...
Dizal Announces DZD8586 and DZD6008 Presentations at 2025 ASCO Annual Meeting
SHANGHAI, April 1, 2025 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that results of its investigational drug...
Zeekr Group Announces March 2025 Delivery Update
HANGZHOU, China, April 1, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced its delivery results for March 2025. In...
Blokees Officially Announces the Launch of the second season of 3rd BFC Creation Competition: Breaking the Cocoon Season
SHANGHAI, April 1, 2025 /PRNewswire/ -- On April 1st, the second season of the third BFC (Blokees Figures Creator) Creation Competition, themed "Breaking the Cocoon Season," was officially launched. This year's competition continues to adopt a...
Lunit Announces Partnership with the National Cancer Institute to Advance AI-Powered Biomarker Research
Collaboration to apply Lunit's AI technologies across NCI's broad spectrum of cancer studies, aiming to accelerate personalized cancer care SEOUL, South Korea, March 31, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered...
China Renaissance Announces 2024 Annual Results: Strong Recovery Driven by Strategic Transformation
HONG KONG, March 31, 2025 /PRNewswire/ -- China Renaissance Holdings Limited ("China Renaissance" or the "Group", stock code: 1911.HK) today announced its annual results for the year ended December 31, 2024 (the "Reporting Period"). Despite a...
Ascletis Announces Positive Interim Results from Its U.S. Phase Ib Trial with ASC30, a Potentially First-in-Class Subcutaneous Injection Small Molecule GLP-1R Agonist
-Ultra-long-acting subcutaneous (SQ) injection formulation of small molecule ASC30 demonstrated a 36-day half-life in patients with obesity, supporting once monthly or less frequent administration. -As previously disclosed, oral tablet formulation...
Entrepreneur Universe Bright Group Announces Audited Financial Results for Fiscal Year Ended December 31, 2024
XI'AN, China, March 31, 2025 /PRNewswire/ -- Entrepreneur Universe Bright Group ("EUBG" or the "Company"), a Nevada corporation, today announced its audited financial results for the fiscal year ended December 31, 2024. The Company reported total...
SMARTIES™ 2025: Celebration of Marketing Excellence - Now Open for Submissions
SINGAPORE, March 31, 2025 /PRNewswire/ -- MMA Global proudly announces the opening of entries for the 2025 SMARTIES™ Awards, the premier marketing awards program that honors trailblazing brands, agencies, and marketers driving innovation and...